{"title":"CLL中PI3K抑制剂耐药性与MAP激酶激活","authors":"R. Simoneaux","doi":"10.1097/01.COT.0000753404.50810.FC","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":19642,"journal":{"name":"Oncology Times UK","volume":"44 1","pages":"8-8"},"PeriodicalIF":0.0000,"publicationDate":"2021-05-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"PI3K Inhibitor Resistance & MAP Kinase Activation in CLL\",\"authors\":\"R. Simoneaux\",\"doi\":\"10.1097/01.COT.0000753404.50810.FC\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":19642,\"journal\":{\"name\":\"Oncology Times UK\",\"volume\":\"44 1\",\"pages\":\"8-8\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-05-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Oncology Times UK\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1097/01.COT.0000753404.50810.FC\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Oncology Times UK","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/01.COT.0000753404.50810.FC","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}